Preclinical studies discovered that Cyr61 played a pivotal role in IL-17-dependent proliferation of FLS in RA and blocking Cyr61 with the specific neutralizing antibody ameliorated the inflammation of the collagen-induced arthritis mice in vivo [7, 8]. The gene discussed is CCN1; the disease is rheumatoid arthritis.